Myriad Genetics Inc

Ownership Transactions Reported by 26 Insiders

Symbol
MYGN on Nasdaq
Industry
In Vitro & In Vivo Diagnostic Substances
Location
322 North 2200 West, Salt Lake City, Utah

Insiders trading volume in the past year

Myriad Genetics Inc executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
Paul J. Diaz President and CEO, Director $26.7M -$5.73M -17.6% May 13, 2024
Samraat S. Raha Chief Operating Officer $6.37M Mar 14, 2024
Mark Verratti Chief Commercial Officer $5.84M Apr 14, 2024
Richard Bryan Riggsbee Chief Financial Officer $5.59M -$1.04M -15.7% Jan 29, 2024
Jerry S. Lanchbury Officer $5.06M Jan 14, 2022
Nicole Lambert Chief Operating Officer $4.29M Oct 31, 2023
Scott J. Leffler Chief Financial Officer $3.62M Mar 14, 2024
Jayne B. Hart Officer $3.3M Mar 1, 2023
Kevin Richard Haas Chief Technology Officer $2.94M Mar 22, 2024
S. Louise Phanstiel Director $2.78M Jun 1, 2023
Heinrich Dreismann Director $2.22M Jun 1, 2023
Dale Muzzey Chief Scientific Officer $2.15M Apr 14, 2024
Dennis Langer Director $2.04M Jun 30, 2022
Margaret Ancona SVP, Chief of Staff $2.02M Mar 22, 2024
Lee Nisley Newcomer Director $1.69M -$157K -8.51% May 13, 2024
Paul Parkinson Fmr EVP Strategy & Innovation $1.67M May 14, 2021
Heinrich Dreismann Director $1.6M Jun 3, 2021
Pamela Wong Chief Legal Officer $1.45M Mar 22, 2024
Colleen F. Reitan Director $1.39M Jun 1, 2023
Daniel Skovronsky Director $1.35M Jun 1, 2023
Rashmi Kumar Director $1.32M Jun 1, 2023
Shereen Solaiman Chief People Officer $1.18M Mar 14, 2024
Eric Santa Former Chief Growth Officer $1.09M Apr 26, 2022
Natalie Munk Chief Accounting Officer $900K Apr 6, 2024
Daniel K. Spiegelman Director $775K Jun 1, 2023
Paul Bisaro Director $468K Jun 1, 2023

Recent Insider Transactions by Companies or Individuals for Myriad Genetics Inc

Insider Class Transaction % Value $ Price $ Shares Shares Owned Date Ownership